EN DE

Healthcare Co Ltd (603313) Fair Value & Analysis

Consumer Cyclical · CN · Market cap 3.4B CNY

HC Healthcare Co Ltd 603313 · SHG
Price¥6.05
Fair Value¥12.21
Upside+101.8%
Quality43/100
Watch Healthcare Co Ltd for free, get notified when fair value or trend changes. Watch for free

Strengths

Trades 50% below our fair value of ¥12.21
Low debt · generates free cash flow

Risks

!Mixed Growth (revenue 5y +6.4 %/yr)
!Loss-making · -1.2% net margin
!Mixed vs. peers (6/12)
!Narrow moat 21/100
Mixed Growth (revenue 5y +6.4 %/yr)
Loss-making · -1.2% net margin
Low debt · generates free cash flow
Mixed vs. peers (6/12)
Narrow moat 21/100
Evidence: High Range ¥8.80 – ¥15.16 Share as image

Fair value as of: Aug 13, 2026

From 16 valuation models · updated 11 days ago

Share price +8.6% over the past month.

Below-average quality, trading 50% below our fair value.

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Track Healthcare Co Ltd and get told automatically when its fair value or trend turns, plus fair value for all 35,000+ stocks. 14 days of Pro free, no card.

What matters now

  • The large discount to fair value meets weak quality (43/100). That raises the risk this is a value trap rather than a bargain.
  • The price is below even our cautious bear case (¥8.80). The market is more pessimistic than our downside scenario.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (5 years)

¥29.34 ¥5.05 Fair Value ¥12.21 Mar 2021 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 13, 2026.

How to read this chart

60‑month range ¥5.05 – ¥29.34 · fair‑value band ¥8.80 – ¥15.16 · the ¥6.05 price screens below the ¥12.21 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Aug 13, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Healthcare Co Ltd (603313) currently trades at ¥6.05, while our model-based Fair Value estimate is ¥12.21, implying the stock looks roughly 101.8% undervalued today. The Quality Score stands at 43/100 (below-average quality), in the Consumer Cyclical sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high), always confirm before acting.

Over the trailing twelve months, Healthcare Co Ltd generated revenue of 9.1B CNY at a net margin of -1.2%. Revenue grew 10.2% year over year. It earns a return on equity of -3.1%. Net debt stands at 983M CNY. Fundamentals as of Aug 13, 2026

Our scenario range runs from ¥8.80 (bear case) to ¥15.16 (bull case); at ¥6.05, the current price sits below that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 44% below its 52-week high and 20% above its 52-week low, currently below its 200-day average. For context, the median of 10 Consumer Cyclical peers we cover trades at -1% fair-value upside, at 102%, 603313 screens cheaper than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model Bear Bear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull Bull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence
Highest evidence
Growth DCF ¥13.36 ¥24.87 ¥45.17 80
Rev-Margin DCF ¥10.10 ¥17.13 ¥27.27 74
ROIC Compounder ¥8.53 ¥11.67 ¥14.36 72
All 16 models by family
DCF Models
FCF DCF ¥13.83 ¥22.81 ¥46.11 38
Owner Earnings ¥5.51 ¥9.95 ¥18.52 31
5Y Revenue Exit ¥10.10 ¥17.00 ¥27.85 39
5Y EBITDA Exit ¥15.62 ¥29.31 ¥49.75 41
10Y Revenue Exit ¥10.96 ¥18.66 ¥29.69 36
10Y EBITDA Exit ¥14.96 ¥28.32 ¥51.74 37
Earnings-Based
EPV ¥7.59 ¥8.55 ¥9.39 59
Dividend Discount
Gordon GGM ¥1.69 ¥3.37 ¥5.10 70
DDM Multi-Stage ¥1.69 ¥2.91 ¥3.55 61
Multiples
EV/EBIT ¥11.56 ¥14.91 ¥18.27 53
EV/EBITDA ¥17.00 ¥22.17 ¥27.35 54
EV/Revenue ¥8.28 ¥11.18 ¥14.09 43
Asset-Based
NCAV (Graham) ¥3.07 ¥4.11 ¥6.13 50
Growth DCF
Growth DCF ¥13.36 ¥24.87 ¥45.17 80
Rev-Margin DCF ¥10.10 ¥17.13 ¥27.27 74
Economic Profit
ROIC Compounder ¥8.53 ¥11.67 ¥14.36 72

Widest divergence: DCF Models (¥18.66) versus Dividend Discount (¥2.91). Highest evidence: Growth DCF (80).

Notify me when 603313 reaches fair value

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.

Key figures & financial health

P/S ratio 0.38 TTM
Net margin -1.2% TTM
Return on equity -3.1% TTM
Return on assets 1.8% TTM
Operating margin 3.8% TTM
EPS (TTM) ¥-0.1900
More key figures
Growth
Revenue (TTM) 9.1B CNY TTM
Revenue growth (YoY) +10.2% 3y avg +3.6%
EPS growth (YoY) +55.0%
Balance sheet & cash flow
Free cash flow 497M CNY FY2025
Net debt 983M CNY FY2025 · ≈ 2.0 yrs of FCF

Figures from reported company fundamentals · as of Aug 13, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 43/100

Of which business quality 43 · Market factors (momentum, volatility) 29

Profitability 36
Margins and returns on capital today
Quality Growth 52
Are margins and returns improving?
Cashflow 38
Earnings quality: real cash, not paper profit
Fin. Strength 37
Balance sheet, leverage, solvency risk
Investment 83
Disciplined investing over empire-building
Low Volatility 60
Calm price path (market factor)
Momentum 19
Price trend over the last 3–12 months (market factor)
52W Momentum 11
Distance to the 52-week high (market factor)
Net Issuance 33
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

All values are scores from 0 to 100 (100 = best against fixed, research-based bands), not percentages. The three market factors (momentum, 52-week proximity, low volatility) are displayed but carry zero weight in the headline number: market sentiment is not a business property.

About the company

Healthcare Co.,Ltd. provides memory foam mattresses and other home products in China. The company offers smart mattresses and sofas, anti-snoring pillows, and electric beds. It sells its products under the MLILY brand name. The company was formerly known as Nantong Hengkang Sponge Products Co., Ltd. Healthcare Co., Ltd.

Full company description

Healthcare Co.,Ltd. provides memory foam mattresses and other home products in China. The company offers smart mattresses and sofas, anti-snoring pillows, and electric beds. It sells its products under the MLILY brand name. The company was formerly known as Nantong Hengkang Sponge Products Co., Ltd. Healthcare Co., Ltd. was founded in 2003 and is based in Rugao, China.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

Healthcare Co Ltd reported revenue of ¥8.9B in FY2025 versus ¥8.1B in FY2021, a compound +2.3%/yr. Reported net income was −¥9.8M in FY2025.

Growth Quality 44/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Latest Revenue (FY 2025)
8.9B CNY
Latest YoY
+5.5%
Avg. revenue growth/yr (3Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+3.6%
Avg. revenue growth/yr (5Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+6.4%
Avg. revenue growth/yr (14Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+20.3%
Value creation/yr We only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed
Revenue +2.3%/yr
FY21 ¥8.1B
FY22 ¥8.0B
FY23 ¥8.0B
FY24 ¥8.4B
FY25 ¥8.9B
Net income
FY21 −¥276M
FY22 ¥41.4M
FY23 ¥107M
FY24 −¥151M
FY25 −¥9.8M
Character of growth · EPS growth decomposed (2013-2024) −11.5 % p.a.
Revenue per share +19.1 pp

of which total revenue +25.4 pp · buybacks/dilution −6.3 pp

EBIT margin −21.9 pp
Tax rate −2.8 pp
Residual (interest, one-offs) −5.9 pp

Absolute contributions in percentage points per year; they sum to the EPS growth rate. Start and end points are 3-year averages (details on hover).

Watch 603313: get an alert when its fair value changes →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Healthcare Co Ltd Fair Value". https://www.fairvalue-calculator.com/stock/603313

Peer Group

Furnishings, Fixtures & Appliances · 323 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 43 · Bottom 25%
Fair Value upside +102% · Top 25%
Return on assets 2% · Below median
Net margin (TTM) -1% · Bottom 25%
Operating margin (TTM) 4% · Below median
Revenue growth 10% · Top 25%
Dividend yield (TTM) 3.7% · Above median
Debt / equity 0.07× · Higher than median

Valuation Multiples vs Furnishings, Fixtures & Appliances median · lower = cheaper

P/B 0.15× · Cheaper than 75% of peers
P/S (TTM) 0.06× · Cheaper than 75% of peers
P/FCF 1.0× · Cheaper than median

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE100 · sector 16
FUTURE51 · sector 0
PAST0 · sector 19
HEALTH97 · sector 98
DIVIDEND75 · sector 56

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Furnishings, Fixtures & Appliances stocks, each showing price versus our Fair Value estimate (as of Aug 13, 2026).

Stock Price Fair Value vs Fair Value
Midea Group 000333 ¥84.34 ¥99.66 +18%
Gree Electric Appliances, Inc 000651 ¥40.23 ¥86.91 +116%
Haier Smart Home Co 600690 ¥21.79 ¥36.04 +65%
King Slide Works Co 2059 12,500 TWD 1,917 TWD -85%
Guangdong Songfa Ceramics Co 603268 ¥173.26 ¥38.83 -78%
SharkNinja, Inc SN $181.24 $89.07 -51%
Somnigroup International Inc SGI $64.25 $31.80 -51%
De'Longhi S.p.A DLG €39.64 €39.34 -1%
Mohawk Industries, Inc MHK $136.86 $119.26 -13%
Hisense Home Appliances Group 000921 ¥27.69 ¥50.62 +83%

Compare Healthcare Co Ltd with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Consumer Cyclical stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Discover undervalued stocks

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screener Filter by region, size and sector Compare tool Two stocks side by side Fama-French 3-Factor Model Calculator Run the Fama-French 3-factor model in seconds: expected return from the market, size and value factors - free, with formula, betas and an example. Peter Lynch Fair Value Formula & Calculator Apply Peter Lynch's fair value formula in seconds: fair P/E ≈ earnings growth (+ dividend) - free, with formula and example.

Frequently asked questions

Is Healthcare Co Ltd (603313) overvalued or undervalued?
As of Aug 13, 2026, our model estimates a fair value of ¥12.21 versus a price of ¥6.05, about +102% (undervalued).
What is the fair value of 603313?
Our model-based fair value for Healthcare Co Ltd is ¥12.21 (as of Aug 13, 2026), built from audited fundamentals. The current price: ¥6.05.
What is the quality score of 603313?
Healthcare Co Ltd has a Quality Score of 43/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of Healthcare Co Ltd (603313)?
Healthcare Co Ltd reported trailing-twelve-month revenue of about 9.1B CNY (latest available figure, as of Aug 13, 2026).
What is the net profit margin of 603313?
The net profit margin of Healthcare Co Ltd is about -1.2%, meaning it is currently running at a net loss. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track Healthcare Co Ltd and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.